Advancing High-Risk / High Reward Science In 2016, The Wistar Institute established the Wistar Science Accelerator Awards through the generosity of the Tobin-Kestenbaum Family, the Schaeffer Family…
Dr. Carolyn Bertozzi received the 2022 Helen Dean King Award from The Wistar Institute in recognition of her outstanding biomedical research on understanding how sugars that coat our cells impact d…
Dr. Sandra Deliard of the Gardini lab is combining genetics and cell biology to better understand cancer. Born in New York City and raised in Philadelphia, Deliard earned her bachelor’s degree in B…
The evolution of machine learning and artificial intelligence is changing the way the contemporary lab looks and functions. Researchers today are discovering that breakthroughs can happen not only …
From southeast China, Dr. Xue Hao, a postdoctoral research fellow in the Rugang Zhang lab at The Wistar Institute, is tackling ovarian cancer. With a degree in Applied Chemistry from Nanjing Agricu…
Think tank Heartland Forward released a new report tracking technology transfers from research institutions that lead to innovations that build stronger economies and The Wistar Institute ranked 3r…
Wistar offers the perfect blend of qualities for cancer researchers to thrive. Challenging science paired with a social cause is the winning formula that propels Dr. Maureen Murphy in her quest to …
Dr. Jason Diaz, The Wistar Institute education program director, moved around R.W. Brown Community Center classroom full of aquariums with turtles and fish, assorted plants, and books. Dr. Diaz’s e…
Researchers in the Weiner Lab developed DNA-launched bispecific T cell engagers that controlled tumor growth and improved survival in glioblastoma. Glioblastoma is one of the most severe and aggres…
A decade-long collaboration between Wistar and ChristianaCare is leading to new discoveries and better treatment for triple-negative breast cancer patients. Dario C. Altieri, M.D., president, CEO, …
